Jagoni, Tarhata .
HRN: 01-88-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/28/2023
02/06/2023
IVTT
500mg
Q8
T/C Incomplete Abortion
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes